Use of d1 / d5 antagonists for the treatment of obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders and autism

摘要

Invention Patent: B "USE OF D1 / D5 ANTAGONISTS FOR THE TREATMENT OF OBSESSIVE COMPULSIVE DISORDERS, SOMATOPHORIC DISORDERS, DISSOCIATIVE DISORDERS, DISTRIBUTIONS OF DISTRIBUTIONS, DISTRIBUTIONS OF DISTRIBUTIONS AND DISTRIBUTES OF DISTRIBUTIONS OF DISTRIBUTES OF DISTRIBUTES OF DISTRIBUTES. a method for the treatment of obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders and autism is described. The disorders are treated by administering an effective amount of a D1 / D5 antagonist.